tanshinone has been researched along with tanshinone ii a in 13 studies
Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) |
---|---|---|---|---|---|
1,445 | 10 | 1,033 | 61 | 0 | 41 |
Protein | Taxonomy | tanshinone (IC50) | tanshinone ii a (IC50) |
---|---|---|---|
Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 4.82 | |
Spike glycoprotein | Betacoronavirus England 1 | 0.8 | |
Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.8 | |
caspase-9 isoform alpha precursor | Homo sapiens (human) | 11.2 | |
caspase-3 isoform a preproprotein | Homo sapiens (human) | 11.2 | |
Telomerase reverse transcriptase | Homo sapiens (human) | 2.75 | |
Transmembrane protease serine 2 | Homo sapiens (human) | 0.8 | |
Procathepsin L | Homo sapiens (human) | 0.8 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.14 | |
Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 1.2 | |
Replicase polyprotein 1ab | Human coronavirus 229E | 0.8 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.1855 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.69 | |
Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 2.14 | |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 2.59 | |
Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 6.855 | |
Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 6.855 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
Authors | Studies |
---|---|
Bastow, KF; Don, MJ; Lee, KH; Lin, YL; Nakamura, S; Sun, CM; Wang, X; Wu, TS; Yu, HJ | 1 |
Dat, NT; Hong, YS; Jin, X; Kim, YH; Lee, D; Lee, JH; Lee, JJ; Lee, K | 1 |
Cheung, CC; Fung, KP; Lai, PB; Lee, WY; Liu, KW; Wong, J; Yeung, JH | 1 |
Adams, M; Fronza, M; Hamburger, M; Heinzmann, B; Laufer, S; Merfort, I; Murillo, R; Ćlusarczyk, S | 1 |
Jarstfer, MB; Keppler, BR; Lee, KH; Soares, J; Wang, X | 1 |
Jeong, HJ; Kim, DW; Kim, JH; Kim, YM; Kwon, HJ; Lee, WS; Park, JY; Park, KH; Park, SJ; Ryu, YB | 1 |
Edwards, CC; Hatfield, MJ; Hyatt, JL; Jeffries, C; Lemoff, A; Potter, PM; Tsurkan, LG; Yan, B | 1 |
Liu, W; Loh, ML; Qu, CK; Tang, LD; Xu, G; Xu, WR; Yu, B | 1 |
Byun, BJ; Chae, CH; Cho, H; Choi, G; Kim, HY; Lee, JY; Park, WK; Ryu, SY; Woo, J | 1 |
Cheung, J; Gary, EN; Rosenberry, TL; Shiomi, K | 1 |
Banerjee, J; Biswas, N; Bural, S; Dey, A; Gain, C; Kar, GK; Rakshit, M; Saha, A; Sarkar, A | 1 |
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J | 1 |
1 review(s) available for tanshinone and tanshinone ii a
Article | Year |
---|---|
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2022 |
12 other study(ies) available for tanshinone and tanshinone ii a
Article | Year |
---|---|
Antitumor Agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Furans; Humans; Pyrones; Receptor, ErbB-2; Receptors, Estrogen; Salvia miltiorrhiza | 2004 |
Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1; Korea; Plants, Medicinal; Salvia miltiorrhiza; Tumor Cells, Cultured | 2007 |
Cytotoxic effects of tanshinones from Salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells.
Topics: Abietanes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Doxorubicin; Drug Resistance, Neoplasm; Humans; Models, Biological; Molecular Structure; Phenanthrenes; Plants, Medicinal; Salvia miltiorrhiza | 2010 |
In vitro cytotoxic activity of abietane diterpenes from Peltodon longipes as well as Salvia miltiorrhiza and Salvia sahendica.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cytotoxins; Drug Screening Assays, Antitumor; Humans; Lamiaceae; Phytotherapy; Plant Extracts; Plant Roots; Salvia; Structure-Activity Relationship | 2011 |
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
Topics: Abietanes; Benzoquinones; Catalase; Cell Line, Tumor; Dithiothreitol; Enzyme Activation; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Oxidation-Reduction; Telomerase | 2011 |
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.
Topics: Abietanes; Cysteine Proteinase Inhibitors; Humans; Kinetics; Protein Binding; Salvia miltiorrhiza; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Ubiquitination | 2012 |
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").
Topics: Abietanes; Algorithms; Camptothecin; Carboxylesterase; Clinical Trials, Phase I as Topic; Drugs, Chinese Herbal; Herb-Drug Interactions; Humans; Irinotecan; Medicine, Chinese Traditional; Molecular Structure; Phenanthrolines; Plant Roots; Salvia miltiorrhiza | 2013 |
Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11).
Topics: Animals; Catalytic Domain; Cell Line, Tumor; Computer-Aided Design; Drug Evaluation, Preclinical; Enzyme Activation; Enzyme Inhibitors; Humans; Mice; Models, Molecular; Mutation; Phenanthrenes; Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2013 |
Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.
Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Molecular Conformation; Polycomb Repressive Complex 2; Structure-Activity Relationship | 2014 |
Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility.
Topics: | 2013 |
Identification of two novel thiophene analogues as inducers of autophagy mediated cell death in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Thiophenes; Unfolded Protein Response | 2021 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |